Chronic Obstructive Pulmonary Disease and COVID-19: A Double Trouble

Chronic Obstructive Pulmonary Disease and COVID-19: A Double Trouble

Coronavirus Disease 2019 (COVID-19) is a respiratory and systemic illness that may progress to severe Acute Respiratory Distress Syndrome (ARDS). There is a pressing need to identify clinical predictors of severe COVID-19 which can help in risk stratification and prognostication. The COVID-19 pand...

Full description

Bibliographic Details
Main Authors:	Jyoti Bajpai, Surya Kant, Ajay Kumar Verma, Avishek Kar
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2021-11-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	angiotensin converting enzyme 2 receptor coronavirus-2019 prognosis respiratory illness steroids
Online Access:	https://jcdr.net/articles/PDF/15648/46660_CE[Ra1]_F[SH]_GC(AnK)_PF1(AG_SS_KM)_PN(KM).pdf

Similar Items

Decreased Heart Rate Variability in COVID-19
by: Chengfen Yin, et al.
Published: (2022-12-01)

Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis
by: Zhidan Yu, et al.
Published: (2021-07-01)

Renin-angiotensin system in the pathogenesis of COVID-19 and possible drug targets
by: Sujay Halkur Shankar, et al.
Published: (2021-01-01)

Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
by: Naci Şenkal, et al.
Published: (2020-07-01)

Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
by: Jordan Swiderski, et al.
Published: (2023-05-01)

Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies
by: Xiao-Ce Dai, et al.
Published: (2021-04-01)

Are angiotensin converting enzyme (ACE1/ACE2) gene variants associated with the clinical severity of COVID-19 pneumonia? A singlecenter cohort study
by: Serdal Baştuğ, et al.
Published: (2022-02-01)

Interaction of SARS-CoV-2 With RAS / ACE2 in the Female Reproductive System
by: Farideh Zafari Zangeneh
Published: (2022-02-01)

Coronavirus disease 2019 and cardiovascular disease
by: Jenn-Yeu Song, et al.
Published: (2023-01-01)

Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality
by: Malindu E. Fernando, et al.
Published: (2021-09-01)

Assessment and strategy development for SARS-CoV-2 screening in wildlife: A review
by: Jignesh Italiya, et al.
Published: (2023-06-01)

Exploring the causes of mild COVID-19 involvement in pediatric patients
by: A. Naserghandi, et al.
Published: (2020-09-01)

NOX-Dependent Signaling Dysregulation in Severe COVID-19: Clues to Effective Treatments
by: Simona Damiano, et al.
Published: (2020-12-01)

Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2
by: John M. Matsoukas, et al.
Published: (2022-07-01)

Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth
by: Kunal Bikram Shaha, et al.
Published: (2020-05-01)

Oral and Periodontal Manifestations of COVID-19 and its Plausible Association with Periodontal Disease
by: Narayane Ramkumar, et al.
Published: (2021-08-01)

Can coronavirus disease 2019 effect on human reproduction?
by: Ali Abdolrazaghnejad, et al.
Published: (2022-01-01)

Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database
by: Zhonglin Li, et al.
Published: (2020-10-01)

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
by: Chunsheng Zhu, et al.
Published: (2020-08-01)

Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019
by: Mudasir S. Andrabi, et al.
Published: (2020-11-01)

Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review
by: Apichet Sirinawasatien, et al.
Published: (2021-11-01)

Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
by: Omonike A. Olaleye, et al.
Published: (2021-03-01)

Potential adverse effects of coronavirus disease 2019 on the cardiovascular system
by: Bing-Yin Wang, et al.
Published: (2021-01-01)

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells
by: Ilaria Caputo, et al.
Published: (2022-05-01)

Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease
by: Pabst S, et al.
Published: (2009-12-01)

Unraveling the Link between Periodontitis and Coronavirus Disease 2019: Exploring Pathogenic Pathways and Clinical Implications
by: En-Chin Lin, et al.
Published: (2023-10-01)

Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus
by: Yu-Huang Liao, et al.
Published: (2020-12-01)

The Potential of the Use of the Flavonoid Fisetin in the Treatment of Coronavirus by Inhibition of Angiotensin Converting Enzyme 2
by: Seyedeh Sara Azadeh, et al.
Published: (2021-11-01)

The efficacy and safety of sitagliptin administration in patients with Covid-19: A randomized clinical trial
by: Nahid Etemadi Toudeshki, et al.
Published: (2023-01-01)

Strategies and Advances in Combating COVID-19 in China
by: Wei Liu, et al.
Published: (2020-10-01)

Herbal medicines in the treatment of coronavirus disease 2019 (COVID-19)
by: Audrey Tolouian, et al.
Published: (2021-05-01)

Effects of the COVID‐19 pandemic on heart failure hospitalizations in Japan: interrupted time series analysis
by: Tetsuji Morishita, et al.
Published: (2022-02-01)

Angiotensin-Converting Enzyme 2 in the Pathogenesis of Renal Abnormalities Observed in COVID-19 Patients
by: Nayara Azinheira Nobrega Cruz, et al.
Published: (2021-08-01)

ACE2 Shedding and the Role in COVID-19
by: Jieqiong Wang, et al.
Published: (2022-01-01)

Angiotensin converting enzyme inhibitors /
by: DeBrue, Anne N.
Published: (c200)

Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D
by: Ming-Yieh Peng, et al.
Published: (2021-05-01)

Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
by: Rami Sommerstein, et al.
Published: (2020-04-01)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021-08-01)

Paying Attention to Circadian Rhythms in the Treatment of COVID-19
by: Atefeh Bakhtazad, et al.
Published: (2020-04-01)

Pulmonary midkine inhibition ameliorates sepsis induced lung injury
by: Jing-Yuan Xu, et al.
Published: (2021-02-01)